Kynam Capital Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,009
| Closed | -$94.9K | – | 29 |
|
|
2023
Q3 | $94.9K | Buy |
6,009
+11
| +0.2% | +$174 | 0.02% | 26 |
|
|
2023
Q2 | $99.6K | Hold |
5,998
| – | – | 0.01% | 22 |
|
|
2023
Q1 | $84K | Sell |
5,998
-40
| -0.7% | -$560 | 0.01% | 33 |
|
|
2022
Q4 | $61.5K | Buy |
6,038
+20
| +0.3% | +$204 | 0.01% | 30 |
|
|
2022
Q3 | $77K | Sell |
6,018
-217
| -3% | -$2.78K | 0.02% | 32 |
|
|
2022
Q2 | $128K | Sell |
6,235
-790
| -11% | -$16.2K | 0.03% | 31 |
|
|
2022
Q1 | $264K | Sell |
7,025
-325
| -4% | -$12.2K | 0.09% | 30 |
|
|
2021
Q4 | $709K | Buy |
+7,350
| New | +$709K | 0.38% | 29 |
|